# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Malignant mesenchymal tumor

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 71-80 of 516 results.
Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride Capsule
Status: Recruiting
Last Changed: Jan 10, 2020
First Received: Jan 10, 2020
Disease(s): Soft Tissue Sarcomas
Intervention(s): Anlotinib Hydrochloride
Locations: Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer Hospital, Zhengzhou, Henan, China
Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma
Status: Recruiting
Last Changed: Sep 24, 2019
First Received: Jul 09, 2019
Disease(s): Soft Tissue Sarcoma
Intervention(s): Apatinib Mesylate, doxorubicin, ifosfamide
Locations: Sun Yat-sen University Cancer Center, Guangzhou, China
SM-88 as Maintenance Therapy for Advanced Ewing's Sarcoma Patients and as Salvage Therapy for Sarcoma Patients
Status: Recruiting
Last Changed: Nov 12, 2019
First Received: Dec 19, 2018
Disease(s): Sarcoma, Ewing, Sarcoma
Intervention(s): Combination metyrosine-derivative, low-dose methoxsalen, phenytoin and sirolimus (MPS)
Locations: Sarcoma Oncology Research Center, Santa Monica, California, United States
Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
Status: Recruiting
Last Changed: Jan 13, 2020
First Received: Jan 21, 2016
Disease(s): Kaposi Sarcoma
Intervention(s): liposomal doxorubicin, pomalidomide
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma
Status: Not yet recruiting
Last Changed: May 15, 2019
First Received: May 15, 2019
Disease(s): Soft Tissue Sarcoma Adult, High Grade Sarcoma
Intervention(s): Anlotinib Hydrochloride, Placebo Oral Tablet
Locations: Cancer Hospital of Sun Yat-sen, Guangzhou, Guangdong, China
Yunnan Cancer Hospital, Kunming, Yunnan, China
Zhengjiang Cancer Hospital, Hangzhou, Zhejiang, China
Fudan University Shanghai Cancer Center, Shanghai, China
The Six People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, China
... and 1 other locations.
Molecular Profiling of Advanced Soft-tissue Sarcomas
Status: Recruiting
Last Changed: Nov 01, 2019
First Received: Dec 21, 2018
Disease(s): Soft Tissue Sarcoma
Intervention(s): Nilotinib, Ceritinib, Capmatinib, Lapatinib, Trametinib, Trametinib and Dabrafenib, Olaparib and Durvalumab, Palbociclib, Glasdegib, TAS-120, Next Generation sequencing exome
Locations: Institut Bergonie, Bordeaux, France
Centre Jean Perrin, Clermont-Ferrand, France
Centre Georges François Leclerc, Dijon, France
Centre Oscar Lambret, Lille, France
Centre Léon Bérard, Lyon, France
... and 11 other locations.
Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)
Status: Not yet recruiting
Last Changed: Nov 07, 2019
First Received: Jun 07, 2018
Disease(s): Sarcoma, Radiosurgery
Intervention(s): Atezolizumab, SBRT
Locations: Centre François BACLESSE, Caen, France
Centre Georges François LECLERC, Dijon, France
Centre Oscar LAMBRET, Lille, France
Centre Léon BERARD, Lyon, France
Institut Paoli CALMETTES, Marseille, France
... and 7 other locations.
Tazemetostat in Combination With Doxorubicin as Frontline Therapy for Advanced Epithelioid Sarcoma
Status: Recruiting
Last Changed: Jan 18, 2020
First Received: Dec 19, 2019
Disease(s): Advanced Soft Tissue Sarcoma, Advanced Epithelioid Sarcoma
Intervention(s): Tazemetostat, Placebo, Doxorubicin HCl
Locations: Sarcoma Oncology Research Center, Santa Monica, California, United States
Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
Sarah Cannon and HCA Research Institute, Nashville, Tennessee, United States
sEphB4-HSA in Treating Patients With Kaposi Sarcoma
Status: Recruiting
Last Changed: Aug 01, 2019
First Received: Jun 15, 2016
Disease(s): Skin Kaposi Sarcoma
Intervention(s): Laboratory Biomarker Analysis, Pharmacological Study, Quality-of-Life Assessment, Recombinant EphB4-HSA Fusion Protein
Locations: UC San Diego Moores Cancer Center, La Jolla, California, United States
UCSD Moores Cancer Center, La Jolla, California, United States
UCLA CARE Center, Los Angeles, California, United States
University of Miami, Miami, Florida, United States
John H. Stroger Jr., Hospital of Cook County, Chicago, Illinois, United States
... and 5 other locations.
LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma
Status: Recruiting
Last Changed: Feb 26, 2019
First Received: Oct 31, 2018
Disease(s): Soft Tissue Sarcoma
Intervention(s): LTX-315 and TILs
Locations: Herlev Hospital, Copenhagen, Denmark